NasdaqGM - Delayed Quote USD

iShares Biotechnology ETF (IBB)

126.49 +0.82 (+0.65%)
At close: April 26 at 4:00 PM EDT
127.64 +1.15 (+0.91%)
After hours: April 26 at 6:28 PM EDT

Top 10 Holdings (50.62% of Total Assets)

SymbolCompany% Assets
AMGN
Amgen Inc. 8.39%
GILD
Gilead Sciences, Inc. 8.21%
REGN
Regeneron Pharmaceuticals, Inc. 8.05%
VRTX
Vertex Pharmaceuticals Incorporated 8.03%
IQV
IQVIA Holdings Inc. 4.47%
MRNA
Moderna, Inc. 3.51%
BIIB
Biogen Inc. 3.06%
MTD
Mettler-Toledo International Inc. 2.77%
ILMN
Illumina, Inc. 2.14%
WAT
Waters Corporation 2.00%

Sector Weightings

SectorIBB
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Stocks 99.86%
Bonds 0.00%

Equity Holdings

Price/Earnings 0.05
Price/Book 0.24
Price/Sales 0.17
Price/Cashflow 0.05
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

ETF Overview

Category Health
Fund Family iShares
Net Assets 7.63B
YTD Daily Total Return -6.80%
Yield 0.30%
Legal Type Exchange Traded Fund

Related Tickers